{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T11:40:40Z","timestamp":1787744440214,"version":"build-2784847793"},"reference-count":136,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T00:00:00Z","timestamp":1696377600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Nonalcoholic fatty liver disease (NAFLD) and its inflammatory and often progressive subtype nonalcoholic steatohepatitis (NASH), have emerged as significant contributors to hepatic morbidity worldwide. The pathophysiology of NAFLD\/NASH is multifaceted, variable, and remains incompletely understood. The pivotal role of liver-resident and recruited macrophages in the pathogenesis of NAFLD and NASH is widely acknowledged as a crucial factor in innate immunity. The remarkable plasticity of macrophages enables them to assume diverse activation and polarization states, dictated by their immunometabolism microenvironment and functional requirements. Recent studies in the field of immunometabolism have elucidated that alterations in the metabolic profile of macrophages can profoundly influence their activation state and functionality, thereby influencing various pathological processes. This review primarily focuses on elucidating the polarization and activation states of macrophages, highlighting the correlation between their metabolic characteristics and the transition from pro-inflammatory to anti-inflammatory phenotypes. Additionally, we explore the potential of targeting macrophage metabolism as a promising therapeutic approach for the management of NAFLD\/NASH.<\/jats:p>","DOI":"10.3389\/fimmu.2023.1257596","type":"journal-article","created":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T08:50:42Z","timestamp":1696409442000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":24,"title":["Macrophage metabolism in nonalcoholic fatty liver disease"],"prefix":"10.3389","volume":"14","author":[{"given":"Wenhui","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,10,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.20294","article-title":"Trends in liver disease etiology among adults awaiting liver transplantation in the United States, 2014-2019","volume":"3","author":"Wong","year":"2020","journal-title":"JAMA Netw Open"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2022.106752","article-title":"Clinical evidence of outcomes following liver transplantation in patients with nonalcoholic steatohepatitis: An updated meta-analysis and systematic review","volume":"104","author":"Zhou","year":"2022","journal-title":"Int J Surg"},{"key":"B3","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s41575-019-0210-2","article-title":"Adaptive immunity: an emerging player in the progression of NAFLD","volume":"17","author":"Sutti","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-018-0082-x","article-title":"The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"16","author":"Kazankov","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathmechdis-012418-013003","article-title":"Innate immune signaling in nonalcoholic fatty liver disease and cardiovascular diseases","volume":"14","author":"Cai","year":"2019","journal-title":"Annu Rev Pathol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.02.033","article-title":"Role of immune responses in the development of NAFLD-associated liver cancer and prospects for therapeutic modulation","volume":"79","author":"Yahoo","year":"2023","journal-title":"J Hepatol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.05.034","article-title":"Natural history of NASH cirrhosis in liver transplant waitlist registrants","volume":"79","author":"Lim","year":"2023","journal-title":"J Hepatol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ccell.2020.09.004","article-title":"Immunometabolic interplay in the tumor microenvironment","volume":"39","author":"Kaymak","year":"2021","journal-title":"Cancer Cell"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1126\/science.aar3932","article-title":"An evolutionary perspective on immunometabolism","volume":"363","author":"Wang","year":"2019","journal-title":"Science"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-021-00529-8","article-title":"A guide to interrogating immunometabolism","volume":"21","author":"Voss","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-020-0291-z","article-title":"Targeting immunometabolism as an anti-inflammatory strategy","volume":"30","author":"P\u00e5lsson-McDermott","year":"2020","journal-title":"Cell Res"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-022-00675-6","article-title":"Macrophage functional diversity in NAFLD - more than inflammation","volume":"18","author":"Barreby","year":"2022","journal-title":"Nat Rev Endocrinol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/s41392-022-01119-3","article-title":"Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver\/steatohepatitis (NAFL\/NASH)","volume":"7","author":"Xu","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2016.70","article-title":"A guide to immunometabolism for immunologists","volume":"16","author":"O\u2019Neill","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00289","article-title":"Macrophage metabolism as therapeutic target for cancer, atherosclerosis, and obesity","volume":"8","author":"Geeraerts","year":"2017","journal-title":"Front Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-020-0379-5","article-title":"Metabolic signaling in T cells","volume":"30","author":"Shyer","year":"2020","journal-title":"Cell Res"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.1013885","article-title":"Glycolysis in tumor microenvironment as a target to improve cancer immunotherapy","volume":"10","author":"Xiao","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-physiol-022516-034339","article-title":"Macrophage polarization","volume":"79","author":"Murray","year":"2017","journal-title":"Annu Rev Physiol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/ni.3324","article-title":"New insights into the multidimensional concept of macrophage ontogeny, activation and function","volume":"17","author":"Ginhoux","year":"2016","journal-title":"Nat Immunol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.immuni.2014.06.008","article-title":"Macrophage activation and polarization: nomenclature and experimental guidelines","volume":"41","author":"Murray","year":"2014","journal-title":"Immunity"},{"key":"B21","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.it.2021.04.007","article-title":"Tissue-resident macrophages: guardians of organ homeostasis","volume":"42","author":"Nobs","year":"2021","journal-title":"Trends Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2022.10.007","article-title":"Macrophages in health and disease","volume":"185","author":"Park","year":"2022","journal-title":"Cell"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2022.10.002","article-title":"Macrophage immunotherapy: overcoming impediments to realize promise","volume":"43","author":"Sly","year":"2022","journal-title":"Trends Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-023-00848-y","article-title":"Tissue-specific macrophages: how they develop and choreograph tissue biology","volume":"23","author":"Mass","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s41392-023-01452-1","article-title":"Macrophages in immunoregulation and therapeutics","volume":"8","author":"Chen","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202004172","article-title":"Tailoring materials for modulation of macrophage fate","volume":"33","author":"Li","year":"2021","journal-title":"Adv Mater"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.47143","article-title":"Kupffer cells in non-alcoholic fatty liver disease: friend or foe","volume":"16","author":"Chen","year":"2020","journal-title":"Int J Biol Sci"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26607","article-title":"M2 Kupffer cells promote M1 Kupffer cell apoptosis: a protective mechanism against alcoholic and nonalcoholic fatty liver disease","volume":"59","author":"Wan","year":"2014","journal-title":"Hepatology"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-023-00807-x","article-title":"Hepatic inflammatory responses in liver fibrosis","volume":"20","author":"Hammerich","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.04.015","article-title":"Mechanisms and disease consequences of nonalcoholic fatty liver disease","volume":"184","author":"Loomba","year":"2021","journal-title":"Cell"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.108654","article-title":"M13 phage coated surface elicits an anti-inflammatory response in BALB\/c and C57BL\/6 peritoneal macrophages","volume":"107","author":"Safari","year":"2022","journal-title":"Int Immunopharmacol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-021-00690-z","article-title":"The hepatic macrophage pool in NASH","volume":"18","author":"Wang","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2022.08.002","article-title":"Liver macrophages in health and disease","volume":"55","author":"Guilliams","year":"2022","journal-title":"Immunity"},{"key":"B34","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1016\/j.immuni.2021.08.006","article-title":"A subset of Kupffer cells regulates metabolism through the expression of CD36","volume":"54","author":"Bl\u00e9riot","year":"2021","journal-title":"Immunity"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.7150\/thno.50928","article-title":"Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes","volume":"11","author":"Han","year":"2021","journal-title":"Theranostics"},{"key":"B36","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.it.2021.12.003","article-title":"Harder, better, faster, stronger: biochemistry and biophysics in the immunosurveillance concert","volume":"43","author":"Tello-Lafoz","year":"2022","journal-title":"Trends Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202002054","article-title":"Engineering macrophages for cancer immunotherapy and drug delivery","volume":"32","author":"Xia","year":"2020","journal-title":"Adv Mater"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01186","article-title":"Resolution of pulmonary inflammation induced by carbon nanotubes and fullerenes in mice: role of macrophage polarization","volume":"11","author":"Lim","year":"2020","journal-title":"Front Immunol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2009.080999","article-title":"Increased hepatic myeloperoxidase activity in obese subjects with nonalcoholic steatohepatitis","volume":"175","author":"Rensen","year":"2009","journal-title":"Am J Pathol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.omtm.2016.11.004","article-title":"Antibody-directed glucocorticoid targeting to CD163 in M2-type macrophages attenuates fructose-induced liver inflammatory changes","volume":"4","author":"Svendsen","year":"2017","journal-title":"Mol Ther Methods Clin Dev"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2020.188434","article-title":"Targeting tumor-associated macrophages for cancer immunotherapy","volume":"1874","author":"Shu","year":"2020","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1002\/cti2.1222","article-title":"Origins and diversity of macrophages in health and disease","volume":"9","author":"Sreejit","year":"2020","journal-title":"Clin Transl Immunol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2019.07.002","article-title":"Macrophage plasticity and function in the eye and heart","volume":"40","author":"Wang","year":"2019","journal-title":"Trends Immunol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.164.12.6166","article-title":"M-1\/M-2 macrophages and the Th1\/Th2 paradigm","volume":"164","author":"Mills","year":"2000","journal-title":"J Immunol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.immuni.2010.05.007","article-title":"Alternative activation of macrophages: mechanism and functions","volume":"32","author":"Gordon","year":"2010","journal-title":"Immunity"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/8148272","article-title":"Regulating the polarization of macrophages: A promising approach to vascular dermatosis","volume":"2020","author":"Peng","year":"2020","journal-title":"J Immunol Res"},{"key":"B47","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/s41573-022-00520-5","article-title":"Macrophages as tools and targets in cancer therapy","volume":"21","author":"Mantovani","year":"2022","journal-title":"Nat Rev Drug Discovery"},{"key":"B48","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/s41577-019-0124-9","article-title":"Immunometabolism at the interface between macrophages and pathogens","volume":"19","author":"Russell","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41423-020-00558-8","article-title":"Hepatic macrophages in liver homeostasis and diseases-diversity, plasticity and therapeutic opportunities","volume":"18","author":"Wen","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aaz0749","article-title":"Lifting the veil on macrophage diversity in tissue regeneration and fibrosis","volume":"4","author":"Perciani","year":"2019","journal-title":"Sci Immunol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-021-00639-2","article-title":"Inflammatory processes in the liver: divergent roles in homeostasis and pathology","volume":"18","author":"Ahmed","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1038\/srep17192","article-title":"Astaxanthin prevents and reverses diet-induced insulin resistance and steatohepatitis in mice: A comparison with vitamin E","volume":"5","author":"Ni","year":"2015","journal-title":"Sci Rep"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathmechdis-012418-012718","article-title":"Diversity, mechanisms, and significance of macrophage plasticity","volume":"15","author":"Locati","year":"2020","journal-title":"Annu Rev Pathol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/s41423-021-00791-9","article-title":"Metabolism of tissue macrophages in homeostasis and pathology","volume":"19","author":"Wculek","year":"2022","journal-title":"Cell Mol Immunol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1080\/13543784.2020.1703949","article-title":"The molecular basis for current targets of NASH therapies","volume":"29","author":"Qureshi","year":"2020","journal-title":"Expert Opin Investig Drugs"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M011695200","article-title":"Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4","volume":"276","author":"Lee","year":"2001","journal-title":"J Biol Chem"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2010.02.029","article-title":"Possible involvement and the mechanisms of excess trans-fatty acid consumption in severe NAFLD in mice","volume":"53","author":"Obara","year":"2010","journal-title":"J Hepatol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2013.04.025","article-title":"Food-derived peroxidized fatty acids may trigger hepatic inflammation: a novel hypothesis to explain steatohepatitis","volume":"59","author":"B\u00f6hm","year":"2013","journal-title":"J Hepatol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1300298","article-title":"Inflammasome-mediated secretion of IL-1\u03b2 in human monocytes through TLR2 activation; modulation by dietary fatty acids","volume":"191","author":"Snodgrass","year":"2013","journal-title":"J Immunol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.2012.45","article-title":"Caspase-1-mediated regulation of fibrogenesis in diet-induced steatohepatitis","volume":"92","author":"Dixon","year":"2012","journal-title":"Lab Invest"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1007\/s00109-014-1170-1","article-title":"NLRP3 inflammasome activation is required for fibrosis development in NAFLD","volume":"92","author":"Wree","year":"2014","journal-title":"J Mol Med (Berl)"},{"key":"B62","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/hep.30401","article-title":"Dietary lipids differentially shape nonalcoholic steatohepatitis progression and the transcriptome of kupffer cells and infiltrating macrophages","volume":"70","author":"McGettigan","year":"2019","journal-title":"Hepatology"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31328","article-title":"Iron chaperone poly rC binding protein 1 protects mouse liver from lipid peroxidation and steatosis","volume":"73","author":"Protchenko","year":"2021","journal-title":"Hepatology"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1186\/1476-9255-8-8","article-title":"Inflammatory Signals shift from adipose to liver during high fat feeding and influence the development of steatohepatitis in mice","volume":"8","author":"Stanton","year":"2011","journal-title":"J Inflammation (Lond)"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa178","article-title":"Role of homeostatic iron regulator protein in hepatic cholesterol metabolism: interaction between Kupffer cells and hepatocytes","volume":"41","author":"Blauw","year":"2020","journal-title":"Eur Heart J"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2020.101146","article-title":"Function of the endolysosomal network in cholesterol homeostasis and metabolic-associated fatty liver disease (MAFLD)","volume":"50","author":"Vos","year":"2021","journal-title":"Mol Metab"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1111\/cas.15710","article-title":"ABCA9, an ER cholesterol transporter, inhibits breast cancer cell proliferation via SREBP-2 signaling","volume":"114","author":"Hwang","year":"2023","journal-title":"Cancer Sci"},{"key":"B68","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1053\/j.gastro.2019.05.002","article-title":"Inhibiting interleukin 11 signaling reduces hepatocyte death and liver fibrosis, inflammation, and steatosis in mouse models of nonalcoholic steatohepatitis","volume":"157","author":"Widjaja","year":"2019","journal-title":"Gastroenterology"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1172\/jci121842","article-title":"STING-mediated inflammation in Kupffer cells contributes to progression of nonalcoholic steatohepatitis","volume":"129","author":"Yu","year":"2019","journal-title":"J Clin Invest"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02852","article-title":"Therapeutic targeting of hepatic macrophages for the treatment of liver diseases","volume":"10","author":"van der Heide","year":"2019","journal-title":"Front Immunol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v12.i46.7413","article-title":"Role of Kupffer cells in the pathogenesis of liver disease","volume":"12","author":"Kolios","year":"2006","journal-title":"World J Gastroenterol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24001","article-title":"Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis","volume":"52","author":"Tilg","year":"2010","journal-title":"Hepatology"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2006.04758.x","article-title":"Predictors reflecting the pathological severity of non-alcoholic fatty liver disease: comprehensive study of clinical and immunohistochemical findings in younger Asian patients","volume":"22","author":"Park","year":"2007","journal-title":"J Gastroenterol Hepatol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-019-0110-2","article-title":"Macrophages: versatile players in renal inflammation and fibrosis","volume":"15","author":"Tang","year":"2019","journal-title":"Nat Rev Nephrol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2022.08.009","article-title":"Resident cardiac macrophages: Heterogeneity and function in health and disease","volume":"55","author":"Zaman","year":"2022","journal-title":"Immunity"},{"key":"B76","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1172\/jci122132","article-title":"Molecular imaging of fibrosis: recent advances and future directions","volume":"129","author":"Montesi","year":"2019","journal-title":"J Clin Invest"},{"key":"B77","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1002\/hep.30990","article-title":"Yes-associated protein in kupffer cells enhances the production of proinflammatory cytokines and promotes the development of nonalcoholic steatohepatitis","volume":"72","author":"Song","year":"2020","journal-title":"Hepatology"},{"key":"B78","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/s41574-023-00880-x","article-title":"Antioxidant liver myeloid cell population identified","volume":"19","author":"Tysoe","year":"2023","journal-title":"Nat Rev Endocrinol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2019.11.311","article-title":"Mechanisms of fibrosis development in nonalcoholic steatohepatitis","volume":"158","author":"Schwabe","year":"2020","journal-title":"Gastroenterology"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathol-121808-102132","article-title":"Nonalcoholic fatty liver disease: pathology and pathogenesis","volume":"5","author":"Tiniakos","year":"2010","journal-title":"Annu Rev Pathol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.04.032","article-title":"Caveats to link in vitro mechanistic mitophagy studies to the pathogenesis of non-alcoholic steatohepatitis","volume":"79","author":"Zhang","year":"2023","journal-title":"J Hepatol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1053\/j.gastro.2020.06.031","article-title":"IRE1A stimulates hepatocyte-derived extracellular vesicles that promote inflammation in mice with steatohepatitis","volume":"159","author":"Dasgupta","year":"2020","journal-title":"Gastroenterology"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-06114-4","article-title":"Tumour extracellular vesicles and particles induce liver metabolic dysfunction","volume":"618","author":"Wang","year":"2023","journal-title":"Nature"},{"key":"B84","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1016\/j.cgh.2021.01.023","article-title":"Weight loss and weight regain in usual clinical practice: results from the TARGET-NASH observational cohort","volume":"20","author":"Malespin","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.06.031","article-title":"Crosstalk between adipose tissue insulin resistance and liver macrophages in non-alcoholic fatty liver disease","volume":"71","author":"Rosso","year":"2019","journal-title":"J Hepatol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-012-0227-0","article-title":"Adiponectin: a key playmaker adipocytokine in non-alcoholic fatty liver disease","volume":"14","author":"Gatselis","year":"2014","journal-title":"Clin Exp Med"},{"key":"B87","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.ebiom.2019.01.009","article-title":"Autocrine CTHRC1 activates hepatic stellate cells and promotes liver fibrosis by activating TGF-\u03b2 signaling","volume":"40","author":"Li","year":"2019","journal-title":"EBioMedicine"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2009.04.011","article-title":"Kupffer cells mediate leptin-induced liver fibrosis","volume":"137","author":"Wang","year":"2009","journal-title":"Gastroenterology"},{"key":"B89","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/s41577-022-00791-4","article-title":"Macrophage quality control of HSCs","volume":"22","author":"Minton","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.R066357","article-title":"Lipotoxic lethal and sublethal stress signaling in hepatocytes: relevance to NASH pathogenesis","volume":"57","author":"Hirsova","year":"2016","journal-title":"J Lipid Res"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2021.101190","article-title":"Stress kinases in the development of liver steatosis and hepatocellular carcinoma","volume":"50","author":"Cicu\u00e9ndez","year":"2021","journal-title":"Mol Metab"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32526","article-title":"Tripartite motif-containing protein 31 confers protection against nonalcoholic steatohepatitis by deactivating mitogen-activated protein kinase kinase kinase 7","volume":"77","author":"Xu","year":"2023","journal-title":"Hepatology"},{"key":"B93","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41392-022-01125-5","article-title":"Regulation of cholesterol homeostasis in health and diseases: from mechanisms to targeted therapeutics","volume":"7","author":"Duan","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"B94","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1146\/annurev-immunol-081619-104850","article-title":"Krebs cycle reborn in macrophage immunometabolism","volume":"38","author":"Ryan","year":"2020","journal-title":"Annu Rev Immunol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(14)61933-4","article-title":"Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial","volume":"385","author":"Neuschwander-Tetri","year":"2015","journal-title":"Lancet"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i39.14430","article-title":"FXR agonist GW4064 alleviates endotoxin-induced hepatic inflammation by repressing macrophage activation","volume":"20","author":"Yao","year":"2014","journal-title":"World J Gastroenterol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/hep.32787","article-title":"Combinatorial targeting of G-protein-coupled bile acid receptor 1 and cysteinyl leukotriene receptor 1 reveals a mechanistic role for bile acids and leukotrienes in drug-induced liver injury","volume":"78","author":"Biagioli","year":"2023","journal-title":"Hepatology"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30513","article-title":"Deficiency of both farnesoid X receptor and takeda G protein-coupled receptor 5 exacerbated liver fibrosis in mice","volume":"70","author":"Ferrell","year":"2019","journal-title":"Hepatology"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.12351","article-title":"Pilot study of liraglutide effects in non-alcoholic steatohepatitis and non-alcoholic fatty liver disease with glucose intolerance in Japanese patients (LEAN-J)","volume":"45","author":"Eguchi","year":"2015","journal-title":"Hepatol Res"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1016\/s2468-1253(20)30186-2","article-title":"Novel antisense inhibition of diacylglycerol O-acyltransferase 2 for treatment of non-alcoholic fatty liver disease: a multicentre, double-blind, randomised, placebo-controlled phase 2 trial","volume":"5","author":"Loomba","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.21037\/hbsn-20-438","article-title":"Non-alcoholic steatohepatitis or metabolic-associated fatty liver: time to change","volume":"10","author":"Shiha","year":"2021","journal-title":"Hepatobiliary Surg Nutr"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(15)00803-x","article-title":"Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study","volume":"387","author":"Armstrong","year":"2016","journal-title":"Lancet"},{"key":"B103","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1089\/ars.2016.6953","article-title":"Gliptins suppress inflammatory macrophage activation to mitigate inflammation, fibrosis, oxidative stress, and vascular dysfunction in models of nonalcoholic steatohepatitis and liver fibrosis","volume":"28","author":"Wang","year":"2018","journal-title":"Antioxid Redox Signal"},{"key":"B104","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.cmet.2008.04.003","article-title":"Alternative M2 activation of Kupffer cells by PPARdelta ameliorates obesity-induced insulin resistance","volume":"7","author":"Odegaard","year":"2008","journal-title":"Cell Metab"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1038\/srep44612","article-title":"Effect of modulation of PPAR-\u03b3 activity on Kupffer cells M1\/M2 polarization in the development of non-alcoholic fatty liver disease","volume":"7","author":"Luo","year":"2017","journal-title":"Sci Rep"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1038\/nature05894","article-title":"Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance","volume":"447","author":"Odegaard","year":"2007","journal-title":"Nature"},{"key":"B107","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1053\/j.gastro.2016.01.038","article-title":"Elafibranor, an agonist of the peroxisome proliferator-activated receptor-\u03b1 and -\u03b4, induces resolution of nonalcoholic steatohepatitis without fibrosis worsening","volume":"150","author":"Ratziu","year":"2016","journal-title":"Gastroenterology"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2021.12.250","article-title":"Molecular signature predictive of long-term liver fibrosis progression to inform antifibrotic drug development","volume":"162","author":"Qian","year":"2022","journal-title":"Gastroenterology"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29544","article-title":"Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis","volume":"67","author":"Krenkel","year":"2018","journal-title":"Hepatology"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29477","article-title":"A randomized, placebo-controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis","volume":"67","author":"Friedman","year":"2018","journal-title":"Hepatology"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.11.082","article-title":"Acute pancreatitis: A multifaceted set of organelle and cellular interactions","volume":"156","author":"Habtezion","year":"2019","journal-title":"Gastroenterology"},{"key":"B112","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/j.1365-2796.2011.02442.x","article-title":"Plasma sCD36 is associated with markers of atherosclerosis, insulin resistance and fatty liver in a nondiabetic healthy population","volume":"271","author":"Handberg","year":"2012","journal-title":"J Intern Med"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1126\/science.aax6594","article-title":"Lowering ceramides to overcome diabetes","volume":"365","author":"Kusminski","year":"2019","journal-title":"Science"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.1039614","article-title":"Circulating soluble CD36 as a novel biomarker for progression and prognosis of HBV-related liver diseases","volume":"13","author":"Cai","year":"2022","journal-title":"Front Microbiol"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.11.021","article-title":"Macrophage activation markers predict mortality in patients with liver cirrhosis without or with acute-on-chronic liver failure (ACLF)","volume":"64","author":"Gr\u00f8nb\u00e6k","year":"2016","journal-title":"J Hepatol"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30862","article-title":"Portal pressure in noncirrhotic portal hypertension: to measure or not to measure","volume":"70","author":"Da","year":"2019","journal-title":"Hepatology"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.09.001","article-title":"A step forward to accurately predict mortality in cirrhotic patients undergoing elective surgery: The role of the hepatic venous pressure gradient","volume":"71","author":"Martin Mateos","year":"2019","journal-title":"J Hepatol"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.07.007","article-title":"The prognostic role of hepatic venous pressure gradient in cirrhotic patients undergoing elective extrahepatic surgery","volume":"71","author":"Reverter","year":"2019","journal-title":"J Hepatol"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1007\/s11605-018-3991-7","article-title":"Non-hepatic abdominal surgery in patients with cirrhotic liver disease","volume":"23","author":"Hickman","year":"2019","journal-title":"J Gastrointest Surg"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2012.04.031","article-title":"Circulating microparticles as disease-specific biomarkers of severity of inflammation in patients with hepatitis C or nonalcoholic steatohepatitis","volume":"143","author":"Kornek","year":"2012","journal-title":"Gastroenterology"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1097\/MCO.0b013e328347970b","article-title":"Adipose tissue macrophages: phenotypic plasticity and diversity in lean and obese states","volume":"14","author":"Morris","year":"2011","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"B122","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/imr.12223","article-title":"Macrophage heterogeneity in tissues: phenotypic diversity and functions","volume":"262","author":"Gordon","year":"2014","journal-title":"Immunol Rev"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1038\/nri3073","article-title":"Protective and pathogenic functions of macrophage subsets","volume":"11","author":"Murray","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1517\/17425247.5.3.309","article-title":"Targeted drug delivery via folate receptors","volume":"5","author":"Zhao","year":"2008","journal-title":"Expert Opin Drug Delivery"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2018.03.001","article-title":"Macrophage-targeted therapeutics for metabolic disease","volume":"39","author":"Peterson","year":"2018","journal-title":"Trends Pharmacol Sci"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2018.09.009","article-title":"The role of flavonoids in autoimmune diseases: Therapeutic updates","volume":"194","author":"Rengasamy","year":"2019","journal-title":"Pharmacol Ther"},{"key":"B127","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1124\/pr.119.018440","article-title":"Targeting janus kinases and signal transducer and activator of transcription 3 to treat inflammation, fibrosis, and cancer: rationale, progress, and caution","volume":"72","author":"Bharadwaj","year":"2020","journal-title":"Pharmacol Rev"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1080\/10717544.2016.1177136","article-title":"Pharmaceutical liposomal drug delivery: a review of new delivery systems and a look at the regulatory landscape","volume":"23","author":"Zylberberg","year":"2016","journal-title":"Drug Delivery"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-013-9501-7","article-title":"Intraperitoneal injection of clodronate liposomes eliminates visceral adipose macrophages and blocks high-fat diet-induced weight gain and development of insulin resistance","volume":"15","author":"Bu","year":"2013","journal-title":"AAPS J"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2015.10.011","article-title":"Novel orally active inhibitors of \u03b2-1,3-glucan synthesis derived from enfumafungin","volume":"25","author":"Apgar","year":"2015","journal-title":"Bioorg Med Chem Lett"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1016\/j.nutres.2009.03.002","article-title":"Increased interleukin-10 but unchanged insulin sensitivity after 4 weeks of (1, 3)(1, 6)-beta-glycan consumption in overweight humans","volume":"29","author":"Kohl","year":"2009","journal-title":"Nutr Res"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1126\/science.aal3535","article-title":"Anti-inflammatory effect of IL-10 mediated by metabolic reprogramming of macrophages","volume":"356","author":"Ip","year":"2017","journal-title":"Science"},{"key":"B133","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12951-021-00777-9","article-title":"Protein liposomes-mediated targeted acetylcholinesterase gene delivery for effective liver cancer therapy","volume":"19","author":"Wang","year":"2021","journal-title":"J Nanobiotechnol"},{"key":"B134","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1038\/s41467-021-22106-2","article-title":"Adipocyte PHLPP2 inhibition prevents obesity-induced fatty liver","volume":"12","author":"Kim","year":"2021","journal-title":"Nat Commun"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2021.121209","article-title":"White adipocyte-targeted dual gene silencing of FABP4\/5 for anti-obesity, anti-inflammation and reversal of insulin resistance: Efficacy and comparison of administration routes","volume":"279","author":"Chung","year":"2021","journal-title":"Biomaterials"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2017.09.023","article-title":"Visceral adipose tissue macrophage-targeted TACE silencing to treat obesity-induced type 2 diabetes","volume":"148","author":"Yong","year":"2017","journal-title":"Biomaterials"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1257596\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T08:50:46Z","timestamp":1696409446000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1257596\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,4]]},"references-count":136,"alternative-id":["10.3389\/fimmu.2023.1257596"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1257596","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,4]]},"article-number":"1257596"}}